Identification and Validation of a Ferroptosis-Related Long Non-Coding RNA (FRlncRNA) Signature to Predict Survival Outcomes and the Immune Microenvironment in Patients With Clear Cell Renal Cell Carcinoma.

Zhou, Zhongbao; Yang, Zhenpeng; Cui, Yuanshan; Lu, Shuai; Huang, Yongjin; Che, Xuanyan; Yang, Liqing; Zhang, Yong

Zhou, Zhongbao; Yang, Zhenpeng; Cui, Yuanshan; Lu, Shuai; Huang, Yongjin; Che, Xuanyan; Yang, Liqing; Zhang, Yong.

Afiliação

Zhou Z; Department of Urology, Beijing TianTan Hospital, Capital Medical University, Beijing, China.
Yang Z; Department of General Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Cui Y; Department of Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, China.
Lu S; Department of General Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Huang Y; Department of Urology, Beijing TianTan Hospital, Capital Medical University, Beijing, China.
Che X; Department of Urology, Beijing TianTan Hospital, Capital Medical University, Beijing, China.
Yang L; Department of Neurology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, China.
Zhang Y; Department of Urology, Beijing TianTan Hospital, Capital Medical University, Beijing, China.

Front Genet ; 13: 787884, 2022.

Article em En | MEDLINE | ID: mdl-35350243

Palavras-chave

clear cell renal cell carcinoma; ferroptosis; immune microenvironment; long non-coding RNAs; overall survival; prognostic signature

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google